Safety and efficacy associated with single-fraction high-dose-rate brachytherapy in localized prostate cancer: a systematic review and meta-analysis.

Hong ZengJindong DaiDehong CaoMinghao WangJinge ZhaoYuhao ZengNanwei XuYandong XieHaolin LiuHao ZengGuangxi SunPeng-Fei Shen

Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2023)

SFHDR is associated with favorable tolerability and suboptimal clinical benefit in patients with localized prostate cancer. Ongoing and planned high-quality prospective studies are necessary to verify its safety and efficacy.

Keyphrases

prostate cancer
high dose
radical prostatectomy
low dose
stem cell transplantation
radiation therapy
open label
randomized controlled trial
squamous cell carcinoma
double blind
locally advanced
placebo controlled